Summary:
This is a 52 week study for patients with Type 1 Diabetes taking insulin injections and not using a insulin pump.
Qualified Participants Must:
• Have Type 1 Diabetes
•
Be taking long-acting insulin injections (detemir or glargine)
•
Be taking meal-time insulin injections
•
Not be using a insulin pump
Qualified Participants May Receive:
Compensation for time and travel available for those who enroll in study.